Clinical Trial Update: Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial update on vasodilator therapy for heart failure with preserved ejection fraction (HFpEF) has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Corporal Michael J. Crescenz VA Medical Center | Conditions: Heart Failure, Congestive Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2022-06-21